Adulteration of products sold as Chinese Herbal medicines for weight loss with thyroid hormones and PCP

被引:13
|
作者
Khazan, M. [1 ]
Hedayati, M. [2 ]
Askari, S. [1 ]
Azizi, F. [1 ]
机构
[1] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Endocrine Res Ctr, Tehran, Iran
[2] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Obes Res Ctr, Tehran, Iran
关键词
Chinese herbal pills; Immunochromatographic; Thyroxine; Triiodothyronine; Phencyclidine; Weight loss; LOSS SUPPLEMENTS; SIBUTRAMINE; INTERNET; NITROSOFENFLURAMINE; HYPERTHYROIDISM; OVERWEIGHT; PATIENT; URINE;
D O I
10.1016/j.hermed.2012.11.003
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Aims: Chinese herbal products for weight loss are popular purchases by women in Iran. They are also available around the world via the internet. The content of some of these popularly purchased products was investigated for the presence of illegal substances and thyroid hormones. Materials and methods: Nine different types of herbal weight loss tablets were obtained from the retail marketplace and subjected to qualitative chemical analysis. Immunochromatographic assays for detection of phencyclidine and radioimmunoassay methods for thyroid hormones (T-3 and T-4) were employed. Results: All products except three contained triiodothyronine (T-3), Magic Slim and 100% Original Super Slim also contained thyroxine (T-4), 0.13 mu mol and 0.81 mu mol per capsule respectively. Phencyclidine (PCP) was found in Herbarceous Essence, Green Lean Super Slim and Fat Loss. Conclusion: The Chinese herbal slimming products analyzed contained thyroid hormones and PCP without labeling their contents. Accurate labeling and good surveillance systems are required to ensure the protection of consumers. Crown Copyright (c) 2013 Published by Elsevier GmbH. All rights reserved.
引用
收藏
页码:39 / 43
页数:5
相关论文
共 50 条
  • [1] A new approach to determining pharmacologic adulteration of herbal weight loss products
    De Carvalho, L. M.
    Cohen, P. A.
    Silva, C. V.
    Moreira, A. P. L.
    Falcao, T. M.
    Dal Molin, T. R.
    Zemolin, G.
    Martini, M.
    FOOD ADDITIVES AND CONTAMINANTS PART A-CHEMISTRY ANALYSIS CONTROL EXPOSURE & RISK ASSESSMENT, 2012, 29 (11): : 1661 - 1667
  • [2] Adulteration of Chinese herbal medicines with synthetic drugs: a systematic review
    Ernst, E
    JOURNAL OF INTERNAL MEDICINE, 2002, 252 (02) : 107 - 113
  • [3] How safe is the use of herbal weight-loss products sold over the Internet?
    Ozdemir, B.
    Sahin, I.
    Kapucu, H.
    Celbis, O.
    Karakoc, Y.
    Erdogan, S.
    Onal, Y.
    HUMAN & EXPERIMENTAL TOXICOLOGY, 2013, 32 (01) : 101 - 106
  • [4] Systematic review on fingerprinting development to determine adulteration of Chinese herbal medicines
    Luo, Yongdi
    Yang, Hongbo
    Tao, Guangcan
    PHYTOMEDICINE, 2024, 129
  • [5] Adulteration of the Herbal Weight Loss Products by the Illegal Addition of Synthetic Antiobesity Medications: A Pilot Study
    Firozian, Farzin
    Nili-Ahmadabadi, Amir
    Moradkhani, Shirin
    Moulaei, Miad
    Fasihi, Zohreh
    Ahmadimoghaddam, Davoud
    JOURNAL OF OBESITY, 2021, 2021
  • [7] Chinese herbal medicines for benign thyroid nodules in adults
    Wu, Wenxun
    Yin, Detao
    Yang, Weimin
    Kan, Quancheng
    Liu, Zhangsuo
    Ren, Xiaoyan
    Zhai, Chenguang
    Zhang, Shengjun
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (03):
  • [8] WEIGHT LOSS FOOD SUPPLEMENTS: ADULTERATION AND MULTIPLE QUALITY ISSUES IN TWO PRODUCTS OF CHINESE ORIGIN
    Ancuceanu, Robert
    Dinu, Mihaela
    Arama, Corina
    FARMACIA, 2013, 61 (01) : 28 - 44
  • [9] Analysis of potential adulteration in herbal medicines and dietary supplements for the weight control by capillary electrophoresis
    Cianchino, Valeria
    Acosta, Gimena
    Ortega, Claudia
    Martinez, Luis D.
    Gomez, Maria R.
    FOOD CHEMISTRY, 2008, 108 (03) : 1075 - 1081
  • [10] Toxicological screening and DNA sequencing detects contamination and adulteration in regulated herbal medicines and supplements for diet, weight loss and cardiovascular health
    Crighton, Elly
    Coghlan, Megan L.
    Farrington, Rachael
    Hoban, Claire L.
    Power, Matthew W. P.
    Nash, Christine
    Mullaney, Ian
    Byard, Roger W.
    Trengove, Robert
    Musgrave, Ian F.
    Bunce, Michael
    Maker, Garth
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2019, 176